February 15, 2018
Gene therapy is an emerging strategy to treat diseases caused by genetic abnormalities. One form of gene therapy involves the direct repair of a defective gene, using genome-editing technology such as CRISPR-Cas9. Despite its therapeutic potential, genome editing can also introduce unwanted and potentially harmful genetic errors that limit its clinical feasibility. In a study published in Genome Research, researchers from Osaka University, report the use of a modified version of CRISPR-Cas9 that can edit genes with substantially fewer errors.
Source: Front Line Genomics
http://www.frontlinegenomics.com/news/19162/new-genome-editing-method-fewer-errors/?utm_source=social%20media&utm_medium=social%20media&utm_campaign=social%20media
